Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L G Durrant

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Cancer Research|November 1, 1989
Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancerV S Byers, R Rodvien, K Grant, et al.
Gut|September 16, 1999
Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7C A Maxwell-Armstrong, L G Durrant, R A Robins, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 1, 1996
Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesions to gastric carcinomaM I Filipe, J M Linehan, L G Durrant, et al.
British Journal of Cancer|October 1, 1987
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progressionL G Durrant, K C Ballantyne, N C Armitage, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 1, 1993
Cell kinetics of the in vitro metaphase arrest technique and the clinical applicationsP S Rooney, P A Clarke, K A Gifford, et al.
British Journal of Cancer|January 1, 1986
Antigenicity of newly established colorectal carcinoma cell linesL G Durrant, R A Robins, M V Pimm, et al.
Journal of Clinical Pathology|December 1, 2009
CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancerM A H Ahmed, A Al-Attar, J Kim, et al.
Clinical and Experimental Immunology|February 1, 1989
Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patientsL G Durrant, V S Byers, P J Scannon, et al.
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugatesM V Pimm, N C Armitage, K Ballantyne, et al.
British Journal of Cancer|December 1, 1987
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugatesL G Durrant, M C Garnett, J Gallego, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Cancer Research|November 1, 1989
Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancerV S Byers, R Rodvien, K Grant, et al.
Gut|September 16, 1999
Increased activation of lymphocytes infiltrating primary colorectal cancers following immunisation with the anti-idiotypic monoclonal antibody 105AD7C A Maxwell-Armstrong, L G Durrant, R A Robins, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 1, 1996
Expression of a peptide epitope of the colonic mucin MUC2 in precursor lesions to gastric carcinomaM I Filipe, J M Linehan, L G Durrant, et al.
British Journal of Cancer|October 1, 1987
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progressionL G Durrant, K C Ballantyne, N C Armitage, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 1, 1993
Cell kinetics of the in vitro metaphase arrest technique and the clinical applicationsP S Rooney, P A Clarke, K A Gifford, et al.
British Journal of Cancer|January 1, 1986
Antigenicity of newly established colorectal carcinoma cell linesL G Durrant, R A Robins, M V Pimm, et al.
Journal of Clinical Pathology|December 1, 2009
CD24 shows early upregulation and nuclear expression but is not a prognostic marker in colorectal cancerM A H Ahmed, A Al-Attar, J Kim, et al.
Clinical and Experimental Immunology|February 1, 1989
Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patientsL G Durrant, V S Byers, P J Scannon, et al.
Cancer Detection and Prevention. Supplement : Official Publication of the International Society for Preventive Oncology, Inc|January 1, 1987
Imaging of primary and metastatic colorectal carcinoma with monoclonal antibody 791T/36 and the therapeutic potential of antibody-drug conjugatesM V Pimm, N C Armitage, K Ballantyne, et al.
British Journal of Cancer|December 1, 1987
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugatesL G Durrant, M C Garnett, J Gallego, et al.
Pageof 9